Fortress Biotech (FBIO) Appoints Lucy Lu to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- S&P 500, Nasdaq fall as chips extend losses; earnings and data in focus
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil prices dip but hold near highest in a month on Middle East tensions
- Citi sees Google, Meta and Amazon capex spending at over $800 billion in 2027
- UnitedHealth shares surge on strong earnings beat and guidance
Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors
December 19, 2022 8:00 AM ESTMIAMI, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (Fortress), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lucy Lu, M.D., has been appointed to its Board of Directors. Dr. Lu is an accomplished executive with over 20 years of experience in a wide range of financial and drug development matters in the biotech and healthcare sectors as an investment banker, equity research analyst and executive at several biotech companies.
Lindsay A. Rosenwald, M.D.,... More
